EUVIMEDEUVIMED entdecken
Open Access

Addressing the Global Threat of Multidrug-Resistant Infections: The Role of Ceftazidime-Avibactam Revisited

Sreejith Raveendran, Deepashree R, Sujatha Shimoga Ravi Kumar, Krishna Karthik

Cureus · 13.05.2024

DOI: 10.7759/cureus.60235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 13.05.2024. Verfasst von Sreejith Raveendran und 3 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology, JSS Medical College and Hospital, JSS Academy of Higher Education and Research, Mysore, IND. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objective Bloodstream infections (BSIs) due to multidrug-resistant Gram-negative bacteria (MDR-GNB) pose a significant global health threat amid rising antimicrobial resistance (AMR). This study aimed to investigate the efficacy of ceftazidime-avibactam (CZA) as a therapeutic option for these infections, addressing the urgent need for novel treatments. Materials and methods This study was conducted over one year in the Department of Microbiology, JSS Medical College and Hospital, Mysuru, India, and employed a laboratory-based prospective design. From a total of 376 positive blood cultures, 147 multidrug-resistant (MDR) organisms were identified, and 100 were randomly selected for final analysis. Susceptibility testing via disk diffusion and minimum inhibitory concentration (MIC) determination was performed to evaluate CZA efficacy.

Results

Klebsiella pneumoniae (K. pneumoniae) was the predominant (78%) organism among the subsets, with varying susceptibility patterns observed across species. The overall CZA susceptibility was 45%, with significant discrepancies between disk diffusion and gold standard testing. Notably, there was limited efficacy against Pseudomonas aeruginosa (P. aeruginosa)

Conclusions

This study underscores the pressing need for reliable testing methods and novel treatment strategies in combating MDR infections. Further research with larger sample sizes is imperative to validate our findings and guide clinicians effectively in addressing this critical health challenge.

Schlagwörter

Stichwörter der Autor:innen

antimicrobial resistanceceftazidime-avibactamgram negative bacteremiagram negative rodsmulti-drug resistant organism (mdro)

Autor:innen und Institutionen

  • Microbiology, JSS Medical College and Hospital, JSS Academy of Higher Education and Research, Mysore, IND.
  • Clinical Microbiology, JSS Medical College and Hospital, JSS Academy of Higher Education and Research, Mysore, IND.
  • Medical Microbiology, JSS Medical College and Hospital, JSS Academy of Higher Education and Research, Mysore, IND.

Zitieren

APA

Raveendran, S., R, D., Shimoga Ravi Kumar, S., & Karthik, K. (2024). Addressing the Global Threat of Multidrug-Resistant Infections: The Role of Ceftazidime-Avibactam Revisited. Cureus. https://doi.org/10.7759/cureus.60235

Vancouver

Raveendran S, R D, Shimoga Ravi Kumar S, Karthik K. Addressing the Global Threat of Multidrug-Resistant Infections: The Role of Ceftazidime-Avibactam Revisited. Cureus. 2024. doi:10.7759/cureus.60235

BibTeX
@article{Raveendran2024,
  author = {Raveendran, Sreejith and R, Deepashree and Shimoga Ravi Kumar, Sujatha and Karthik, Krishna},
  title = {Addressing the Global Threat of Multidrug-Resistant Infections: The Role of Ceftazidime-Avibactam Revisited},
  journal = {Cureus},
  year = {2024},
  doi = {10.7759/cureus.60235}
}
Kostenlos starten →